Introduction
There has been considerable recent discussion on the influence of the intraglomerular deposition of fibrin on the natural history of glomerulonephritis and of experimentally induced renal disease (Vassalli, Simon, and Rouiller, 1963; Vassalli and McCluskey, 1965; Wardle and Taylor, 1968; Humair, Potter, and Kwaan, 1969a) . In particular, it has been suggested that proliferation of endothelial and mesangial cells with progressive glomerular sclerosis might be a response to the deposition of fibrin within the glomerular capillaries, and it has been claimed that anticoagulant therapy prevents these changes (Vassalli et al., 1963; Kincaid-Smith, Saker, and Fairley, 1968; Kwaan, 1969b; Kincaid-Smith, Laver, and Fairley, 1970; Herdman et al., 1970) . Much of the fibrin formed naturally in vivo is removed by fibrinolysis by which an insoluble gel is converted to soluble polypeptide fragments known as fibrin/fibrinogen degradation products (F.D.P.).
The concentration of serum F.D.P. has been found to reflect the activity and severity of renal lesions in which glomerular proliferation is prominent (Steihm and Trygstadt, 1969) . However, other non-renal conditions such as deep venous thrombosis and disseminated intravascular coagulation may be associated with a rise in serum F.D.P. (Ruckley et al., 1970; Merskey, Johnson, Kleiner, and Wohl, 1967) , and the currently available techniques do not detect abnormalities in the serum when fibrin deposition and lysis are localized and/or minimal as in the case of transplanted kidneys (Colman, Braun, Busch, Dammin, and Merrill, 1969) . The urinary concentration of F.D.P. probably reflects more closely the extent of fibrinolysis in the renal tract (Clarkson, Morton, and Cash, 1970) and in the present study a sensitive and quantitative immunoassay has been used to examine both serum and urine values in patients with glomerulonephritis.
Patients and Methods
One hundred and seventy-two patients with glomerulonephritis were studied. The diagnosis was made on the basis of clinical, haematological, and biochemical findings and on the light and electron microscopic appearances of material obtained in each case by needle renal biopsy.
CLASSIFICATION OF GLOMERULONEPHRITIS
Proliferative forms of glomerulonephritis were diagnosed when histological examination showed diffuse or focal proliferation of endothelial and mesangial cells. On electron microscopic examination the presence of material in the glomerulus with the appearance of fibrin or its degradation products (Clarkson, MacDonald, Fuster, Cash, and Robson, 1970) was further evidence of this diagnosis. Among the proliferative category three subgroups-that is, polyarteritis nodosa, membranoproliferative (lobular) glomerulonephritis (Cameron, Glasgow, Ogg, and White, 1970) , and acute necrotizing glomerulonephritis-were identified histologically. On clinical grounds further subdivision was possible into acute poststreptococcal glomerulonephritis, glomerulonephritis associated with HenochSchonlein purpura, and Goodpasture's syndrome. Positive antinuclear factor and the presence of L.E. cells, together with the typical histological and ultrastructural abnormalities (Muehrcke, Kark, Pirani, and Pollak, 1957; Baldwin, Lowenstein, Rothfield, Gablo, and McCluskey, 1970) , distinguished systemic lupus erythematosus (S.L.E.) glomerulonephritis from other proliferative forms. In the presentation of data on serum and urine F.D.P. (see below) most cases have been considered together as unspecified proliferative forms, though S.L.E. and membranoproliferative glomerulonephritis are considered separately.
The diagnosis of membranous (Pollak, Rosen, Pirani, Muehrcke, and Kark, 1968) and minimal lesion glomerulonephritis (MacDonald, Lambie, and Robson, 1959) was based on their histological and ultrastructural appearances.
ELECTRON MICROSCOPIC STUDIES
In 51 patients with proliferative glomerulonephritis in whom the renal biopsy was taken during or within one month of the study (see below) the degree of intraglomerular fibrin deposition as detected by electron microscopy was correlated with maximum recorded urinary F.D.P. concentration as: 0 = no fibrin detected, + = rarefied layer between basement membrane and endothelium containing odd strands of fibrin, + + = dark deposits between basement membrane and endothelium, + + + = fibrin projecting into capillary lumen and between endothelial cells, + + + + = glomerular capillary thrombosis.
ACTIVITY OF DISEASE
The activity of the disease in each patient was assessed in the light of information available at the time of the urinary study (see below). Serum and urinary F.D.P. were estimated in all patients by the tanned red cell haemagglutination inhibition immunoassay (Merskey, Kleiner, and Johnson, 1966; Das, 1970 
Results
The number of patients in each disease group and the number with active disease during the period of study are shown in Table I . In 83 cases biopsy was performed during or within a period of one month of the study and in these the histological and clinical evaluations of disease activity were in close agreement. Fig. 1 (7), acute necrotizing (7), Henoch-Schonlein purpura (4), polyarteritis nodosa (4), familial nephritis (3), Goodpasture's syndrome (1), partial lipodystrophy (1), and mixed cryoglobulinaemia (1). (The disease was considered "active" in all patients in these categories.)
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Apart from four patients all cases excreted F.D.P. in a concentration greater than 2 ueg/ml at some stage (Fig. 3) . In those in whom the disease was inactive the F.D.P. concentration never exceeded.2 jig/ml. The close relationship between the urinary F.D.P. concentration and the extent of intraglomerular fibrin deposition as judged by electron microscopy in 51 cases is shown in Table II .
No significant abnormality of urine F.D.P. excretion was detected in the patients with polycystic disease, and in those with pyelonephritis or lower urinary tract infection the values never exceeded 0-5 ,ug/ml. which persisted when the disease remained active and became more pronounced in rapidly progressive cases (Fig. 2) . Excretion ceased abruptly when the disease was self-limiting (Fig. 2) . 24-hour specimen. In unspecified proliferative glomerulonephritis, S.L.E., and membranoproliferative glomerulonephritis no relation was found between F.D.P. concentration or 24-hour F.D.P. excretion and the l1egree of proteinuria (Fig. 4) or its selectivity to plasma proteins (P> 0 1). This was also true when the groups were analysed individually. In membranous and minimal lesion glomerulonephritis the F.D.P. concentration and excretion were closely related to the degree of proteinuria (Fig. 3) but not to protein selectivity (P> 01 for each disease).
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Fibrinogenolysis by the in vitro action of streptokinase on human fibrinogen resulted in the formation of degradation products similar in size to those defined by Marder, Shulman, and Carroll (1969 (Fig. 5) . (Merskey et al., 1967;  r0omerulonephritis Ruckley et al., 1970) , and the serum determination is relatively insensitive in moderate and or localized renal involvement.
On the other hand, the urinary F.D.P. concentration when **... measured daily seems to provide more information concerning the diagnosis, activity, severity, and prognosis. Healthy normotensive subjects excrete negligible amounts of F.D.P. (Clarkson, Morton, and Cash, 1970) In minimal lesion and membranous glomerulonephritis, in which there is no histological and ultrastructural evidence of the deposition of glomerular fibrin, urinary F.D.P. excretion did not concentration of F.D.P. was 2 t±g/ml or more. In these circumstances the diagnosis of a proliferative glomerulonephritis was almost certain. Daily measurement in unspecified proliferative glomerulonephritis, S.L.E., and membranoproliferative glomerulonephritis also provided information relevant to the activity, natural history, and prognosis. In poststreptococcal glomerulonephritis, for example, after a limited period of activity there was abrupt cessation of F.D.P. excretion at the time of clinical recovery. Where clinical evidence of activity persisted large fluctuations of F.D.P. concentration occurred which increased in magnitude in progressive disease and were similar to the cyclical peaks noticed in renal homograft rejection (Clarkson, Morton, and Cash, 1970) . This cyclical pattern may provide a clue to the nature of the inflammatory stimulus and presumably either reflects a fluctuating inflammatory activity or periodic attempts by the fibrinolytic mechanisms to degrade intraglomerular fibrin. Against this latter hypothesis, however, was the absence of parallel changes between excreted urokinase and F.D.P.
Finally, and perhaps most significant of all, in proliferative glomerulonephritis the daily estimation of urine F.D.P. may provide a tool which, at minimal inconvenience to the patient, facilitates the continual review of specific therapy (Vermylen, Dotremont, Gaetano, Donati, and Michielsen, 1970; Clarkson, Cash, MacDonald, Fuster, Lambie, and Robson, 1971 
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Chloramphenicol has been the drug of choice for the treatment of typhoid fever for over 20 years. However, the rare but serious side effect of aplastic anaemia and the significant incidence of relapse and chronic carrier state following treatment of typhoid with chloramphenicol has led to a search for a safer and more effective agent. The emergence of strains of S. typhi resistant to chloramphenicol (Agarwal, 1962) has added a further stimulus to this quest. In vitro most salmonella species are sensitive to ampicillin (Garrod and O'Grady, 1968) . However, enteric fever responds less rapidly to ampicillin than to
